Compare Paycom Software Inc (PAYC) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Paycom Software Inc vs Revvity Inc — how do they compare? Paycom Software Inc trades at $214.7 (market cap $9.72B), while Revvity Inc trades at $124.14 (market cap $13.82B). The key difference: Revvity Inc is the larger of the two by market cap, and Paycom Software Inc pays the higher dividend (0.7%). Which is the better fit depends on your goals.
| PAYC | RVTY | |
|---|---|---|
Market Cap | $9.72B | $13.82B |
Sector | Technology | Technology |
52-Week High | $240.52 | $130.94 |
52-Week Low | $113.59 | $82.26 |
Enterprise Value | $10.50B | $16.14B |
Dividend Yield | 0.7% | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Paycom Software (PAYC) trades at $219.16, down 5.4% over 24 hours, with a mixed technical signal and strong fundamentals. The stock shows robust profitability with a 22.78% net income margin and consistent earnings beats, including Q2 2026 EPS of $2.78 versus $2.38 expected. Recent news highlights momentum from raised guidance and institutional buying, while analyst consensus is divided with a $231.70 price target.
Outlook is cautiously optimistic due to solid revenue growth and margin expansion, but risks include competitive pressures and market volatility. The stock's current dip near support at $216 may present a buying opportunity for investors focused on long-term fundamentals, though hold-rated analyst sentiment suggests patience amid near-term fluctuations.
RVTY trades at $127.08, down 2.41% on the day, with a bullish technical signal from moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, driven by diagnostics strength and improved cash flow. Recent news includes the acquisition of Human Cell Design and the launch of the SuperFlex prenatal screening system.
Outlook is positive with 52% analyst buy ratings and a $135.25 consensus price target, implying ~6% upside. Risks include a premium valuation (P/E 61.1) and execution of growth initiatives. Strong institutional interest, such as Bank of New York Mellon's $78.77 million investment, supports confidence in the stock's trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Paycom Software Inc
Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
